CATALYST BIOSCIENCES INC's ticker is CBIO and the CUSIP is 14888D208. A total of 93 filers reported holding CATALYST BIOSCIENCES INC in Q1 2021. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $290,000 | -13.9% | 66,951 | 0.0% | 0.03% | -31.8% |
| Q1 2021 | $337,000 | -20.1% | 66,951 | 0.0% | 0.04% | -18.5% |
| Q4 2020 | $422,000 | +46.5% | 66,951 | 0.0% | 0.05% | -6.9% |
| Q3 2020 | $288,000 | -26.7% | 66,951 | 0.0% | 0.06% | -24.7% |
| Q2 2020 | $393,000 | +34.1% | 66,951 | 0.0% | 0.08% | -51.6% |
| Q1 2020 | $293,000 | -35.7% | 66,951 | 0.0% | 0.16% | -3.0% |
| Q4 2019 | $456,000 | – | 66,951 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 3,076,376 | $13,321,000 | 6.97% |
| 22NW, LP | 1,429,242 | $6,189,000 | 1.66% |
| Ghost Tree Capital, LLC | 1,000,000 | $4,330,000 | 1.19% |
| ACUTA CAPITAL PARTNERS, LLC | 685,000 | $2,966,000 | 1.18% |
| Sio Capital Management, LLC | 623,892 | $2,701,000 | 0.67% |
| Parkman Healthcare Partners LLC | 393,449 | $1,704,000 | 0.37% |
| Nantahala Capital Management | 2,531,360 | $10,961,000 | 0.31% |
| AlphaCentric Advisors LLC | 182,500 | $790,000 | 0.22% |
| Ikarian Capital, LLC | 581,200 | $2,518,000 | 0.20% |
| Tibra Equities Europe Ltd | 79,200 | $343,000 | 0.11% |